PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,185,766
Total 13F shares
51,696,984
Share change
+246,162
Total reported value
$323,689,509
Put/Call ratio
17%
Price per share
$6.26
Number of holders
104
Value change
+$3,281,155
Number of buys
58
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q2 2023

As of 30 Jun 2023, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,696,984 shares. The largest 10 holders included ORBIMED ADVISORS LLC, BlackRock Inc., JPMORGAN CHASE & CO, Boxer Capital, LLC, Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, Euclidean Capital LLC, Verition Fund Management LLC, CITADEL ADVISORS LLC, and VANGUARD GROUP INC. This page lists 104 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.